Showing results (1-10 of 75) with videos related to
Sort By:
Pageof 8
Expert Opinion on Investigational Drugs|April 30, 2020
Emerging myelin repair agents in preclinical and early clinical development for the treatment of multiple sclerosisStefan Gingele, Martin StangelFrontiers in Cellular Neuroscience|March 25, 2014
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learnedViktoria Gudi, Stefan Gingele, Thomas Skripuletz, et al.Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Regenerative Effects of CDP-Choline: A Dose-Dependent Study in the Toxic Cuprizone Model of De- and RemyelinationViktoria Gudi, Nora Schäfer, Stefan Gingele, et al.Journal of Neurology|April 29, 2024
Diagnostic value of neurofilaments in differentiating motor neuron disease from multifocal motor neuropathyCamilla Wohnrade, Tabea Seeliger, Stefan Gingele, et al.Journal of Molecular Neuroscience : MN|January 27, 2017
The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone ModelLaura Salinas Tejedor, Tanja Wostradowski, Stefan Gingele, et al.Brain Research|October 6, 2009
Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal gangliaFriederike Pott, Stefan Gingele, Tim Clarner, et al.Melanoma Research|March 12, 2019
Acute progressive neuropathy-myositis-myasthenia-like syndrome associated with immune-checkpoint inhibitor therapy in patients with metastatic melanomaNora Möhn, Kurt-Wolfram Sühs, Stefan Gingele, et al.Cells|April 16, 2020
Delayed Demyelination and Impaired Remyelination in Aged Mice in the Cuprizone ModelStefan Gingele, Florian Henkel, Sandra Heckers, et al.Journal of Neuroinflammation|May 27, 2018
Immunophenotyping of cerebrospinal fluid cells by ChipcytometryMartin W Hümmert, Sascha Alvermann, Stefan Gingele, et al.Histology and Histopathology|June 26, 2015
Oligodendroglial markers in the cuprizone model of CNS de- and remyelinationLaura Salinas Tejedor, Viktoria Gudi, Valeria Kucman, et al.Pageof 8